Analyst Recommendations
2.00 0.11(5.80%)10/04/2024
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Neutral | 4 |
Buy | 1 |
Market Outperform | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades